Drug-Resistant Malaria 'Huge Threat' to Global Health
Strain found on Myanmar-India border will need 'vigorous effort' to be contained, researchers say
Cases of drug-resistant malaria have been multiplying in Southeast Asia, particularly along the border of India and Myanmar, in what health experts are warning is a "huge threat" to global health that will require "vigorous international effort" to contain.
The strain has been found in Laos, Cambodia, Thailand, Myanmar, and Vietnam, according to a report published in Lancet Infectious Diseases.
The location of the outbreak is important, Thailand-based medical researcher and report co-author Dr. Charles Woodrow told the BBC on Thursday. "[T]hat's clearly a threat and in the future is likely to lead to extension of the problem to neighboring areas," he said.
The medication in question is artemisinin, which is typically given as part of a combination therapy. Resistance to artemisinin would "inevitably" lead to its failure, Woodrow continued. "If this were to spread into India, malaria will continue to affect rural populations there, but there may not be an immediate effect on cure-rate."
The researchers found that "artemisinin resistance extends over more of southeast Asia than had previously been known, and is now present close to the border with India. This finding expands the area in which containment and elimination are needed to prevent the possibility of global spread of artemisinin resistance."
According to the World Health Organization, malaria death rates dropped by 47 percent around the world since 2000. In 2013, WHO recorded roughly 198 million malaria cases around the world, with an estimated 584,000 deaths, 90 percent of which occurred in WHO African Region.
The report concluded: "A vigorous international effort to contain this enormous threat is needed."
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Cases of drug-resistant malaria have been multiplying in Southeast Asia, particularly along the border of India and Myanmar, in what health experts are warning is a "huge threat" to global health that will require "vigorous international effort" to contain.
The strain has been found in Laos, Cambodia, Thailand, Myanmar, and Vietnam, according to a report published in Lancet Infectious Diseases.
The location of the outbreak is important, Thailand-based medical researcher and report co-author Dr. Charles Woodrow told the BBC on Thursday. "[T]hat's clearly a threat and in the future is likely to lead to extension of the problem to neighboring areas," he said.
The medication in question is artemisinin, which is typically given as part of a combination therapy. Resistance to artemisinin would "inevitably" lead to its failure, Woodrow continued. "If this were to spread into India, malaria will continue to affect rural populations there, but there may not be an immediate effect on cure-rate."
The researchers found that "artemisinin resistance extends over more of southeast Asia than had previously been known, and is now present close to the border with India. This finding expands the area in which containment and elimination are needed to prevent the possibility of global spread of artemisinin resistance."
According to the World Health Organization, malaria death rates dropped by 47 percent around the world since 2000. In 2013, WHO recorded roughly 198 million malaria cases around the world, with an estimated 584,000 deaths, 90 percent of which occurred in WHO African Region.
The report concluded: "A vigorous international effort to contain this enormous threat is needed."
Cases of drug-resistant malaria have been multiplying in Southeast Asia, particularly along the border of India and Myanmar, in what health experts are warning is a "huge threat" to global health that will require "vigorous international effort" to contain.
The strain has been found in Laos, Cambodia, Thailand, Myanmar, and Vietnam, according to a report published in Lancet Infectious Diseases.
The location of the outbreak is important, Thailand-based medical researcher and report co-author Dr. Charles Woodrow told the BBC on Thursday. "[T]hat's clearly a threat and in the future is likely to lead to extension of the problem to neighboring areas," he said.
The medication in question is artemisinin, which is typically given as part of a combination therapy. Resistance to artemisinin would "inevitably" lead to its failure, Woodrow continued. "If this were to spread into India, malaria will continue to affect rural populations there, but there may not be an immediate effect on cure-rate."
The researchers found that "artemisinin resistance extends over more of southeast Asia than had previously been known, and is now present close to the border with India. This finding expands the area in which containment and elimination are needed to prevent the possibility of global spread of artemisinin resistance."
According to the World Health Organization, malaria death rates dropped by 47 percent around the world since 2000. In 2013, WHO recorded roughly 198 million malaria cases around the world, with an estimated 584,000 deaths, 90 percent of which occurred in WHO African Region.
The report concluded: "A vigorous international effort to contain this enormous threat is needed."